investors – Health

ESG tech sector M&A momentum on the rise as regulators and investors demand robust reporting, reveals Hampleton Partners

93 M&A deals globally target ESG firms in the first half of 2022 London, UK – 23 August 2022. The Environmental, Social & Governance Technology M&A Market Report from Hampleton Partners, the international M&A and corporate finance advisory firm for technology companies, reveals that the first half of 2022 saw 93 deals globally target an… Read More »

Opdivo will keep growing, Bristol-Myers says, trying to talk investors off the ledge

It’s no secret that Bristol-Myers Squibb’s investors are feeling skittish after a pair of negative Opdivo developments last week. And on Thursday’s third-quarter conference call, executives plunged right into their doubts. After a two-day period in which the company 1) saw competitive kidney cancer data posted by Opdivo archrival Keytruda from Merck and 2) produced… Read More »